Foresee Pharmaceuticals Co., Ltd.
Foresee Pharmaceuticals Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward) | Group 3 Pulmonary Hypertension | Recruiting | Phase 2 | 2026-09-21 | NCT06475781 | |
| Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) | Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-07-20 | NCT07191535 | |
| Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum | Pathologic Processes, Pathological Conditions, Signs and Symptoms, pulmonary emphysema | Recruiting | Not stated | 2024-11-20 | NCT04761393 |